Insulin aspart, recombinant Subcutaneous and Zovirax Suspension
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Zovirax Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: acyclovir
Brand name: Sitavig, Zovirax
Synonyms: Zovirax
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Zovirax Topical
- Insulin aspart, recombinant Subcutaneous-ZTlido
- Insulin aspart, recombinant Subcutaneous-Zubsolv
- Insulin aspart, recombinant Subcutaneous-Zulresso
- Insulin aspart, recombinant Subcutaneous-Zumandimine
- Insulin aspart, recombinant Subcutaneous-Zuplenz
- Zovirax Suspension-Insulin degludec
- Zovirax Suspension-Insulin Degludec (U-100) Prefilled Pens
- Zovirax Suspension-Insulin Degludec (U-100) Vials
- Zovirax Suspension-Insulin Degludec (U-200) Prefilled Pens
- Zovirax Suspension-Insulin degludec and liraglutide
- Zovirax Suspension-Insulin degludec and liraglutide Subcutaneous